Michael McFaddenCEO at Alpha Cognition, Inc.
Mr. McFadden brings more than 30 years of successful leadership experience spanning pre-IND drug discovery through the commercialization and has launched over a dozen therapies in neurology, psychiatry, endocrinology and urology. Mr. McFadden most recently served as chief commercial officer of MPower Health, an orthopedic healthcare services company focused on value-based care solutions and interoperative neuromonitoring clinical services. Previously, Mr. Mcfadden has served on executive teams with Urovant Sciences, a urology based public company, and Avanir Pharmaceuticals, a CNS focused company, which was purchased by Otsuka Pharmaceutical Co, Ltd. In 2015. Earlier in his career, Mr. Mcfadden served in leadership roles at Amylin Pharmaceuticals, Pharmacia, and Eli Lilly and Company. He serves on advisory boards for MPower Health, and also MindLab, LLC, a company focused on therapeutics for pain management. Mr. Mcfadden holds a Bachelors In Business Administration from Northeast Louisiana University.